Vicarious Surgical (RBOTW) Research & Development (2020 - 2025)
Vicarious Surgical (RBOTW) reported Research & Development of $8.0 million for Q3 2025, down 25.99% year-over-year from $10.8 million in Q3 2024, and down 11.68% on a QoQ basis from $9.0 million in Q2 2025.
Vicarious Surgical (RBOTW) has 6 years of Research & Development data on file, last reported at $8.0 million in Q3 2025.
- Quarterly Research & Development fell 25.99% year-over-year to $8.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $34.9 million (down 13.05% YoY) and the FY2024 annual result came in at $40.2 million, down 15.6% from the prior year.
- Research & Development retreated to $8.0 million in Q3 2025 per RBOTW's latest filing, from $9.0 million in the prior quarter.
- Across five years, Research & Development topped out at $13.4 million in Q1 2023 and bottomed at $3.6 million in Q1 2021.
- The 5-year median for Research & Development is $9.8 million (2022), against an average of $9.5 million.
- The widest annual swing landed in 2021, when Research & Development soared 212.14%; it then retreated 28.7% in 2023.
- Tracing RBOTW's Research & Development over 5 years: stood at $9.3 million in 2021, then gained by 28.33% to $11.9 million in 2022, then slipped by 28.7% to $8.5 million in 2023, then retreated by 0.06% to $8.5 million in 2024, then dropped by 5.55% to $8.0 million in 2025.
- Per Business Quant, the three latest RBOTW Research & Development figures stand at $8.0 million (Q3 2025), $9.0 million (Q2 2025), and $9.4 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.99 Mn |
| Jun 30, 2025 | 9.05 Mn |
| Mar 31, 2025 | 9.42 Mn |
| Dec 31, 2024 | 8.46 Mn |
| Sep 30, 2024 | 10.80 Mn |
| Jun 30, 2024 | 10.92 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Dec 31, 2023 | 8.47 Mn |
| Sep 30, 2023 | 13.04 Mn |
| Jun 30, 2023 | 12.71 Mn |
| Mar 31, 2023 | 13.36 Mn |
| Dec 31, 2022 | 11.88 Mn |
| Sep 30, 2022 | 12.12 Mn |
| Jun 30, 2022 | 10.06 Mn |
| Mar 31, 2022 | 9.85 Mn |
| Dec 31, 2021 | 9.26 Mn |
| Sep 30, 2021 | 5.19 Mn |
| Jun 30, 2021 | 4.01 Mn |
| Mar 31, 2021 | 3.61 Mn |
| Dec 31, 2020 | 2.97 Mn |
| Sep 30, 2020 | 2.50 Mn |